lack patients with atrial fibrillation are significantly less likely to receive oral anticoagulants – particularly newer, more effective versions – than white and Hispanic patients, according to a new study published today in JAMA Cardiology.

First author Utibe R. Essien, M.D., M.P.H., assistant professor in the University of Pittsburgh Division of General Internal Medicine, used the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II registry to source patient data for the study. He conducted the research during his fellowship at Massachusetts General Hospital.